ASMB ASSEMBLY BIOSCIENCES INC
Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about ASSEMBLY BIOSCIENCES INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8079
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8051
Recent analyst activity · last 90 days
Our tracked history has 7 reports on ASMB from 6 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it and 2 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: UBS lowered its target from $52.00 (set 1 Sep 2026) to $48.00 on 3 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Citizens JMP | Roy Buchanan | Buy | 2 Apr 2026 | 38.00 USD |
| Guggenheim | Vamil Divan | Buy | 17 Aug 2026 | 43.00 USD |
| H.C. Wainwright | Patrick R. Trucchio | Buy | 18 Aug 2026 | 50.00 USD |
| Jefferies | Dennis Ding | Buy | 1 Jul 2026 | 62.00 USD |
| Mizuho | Salim Syed | ConflictConflicting reports · excluded | 1 Sep 2026 | Conflicting reports · excluded |
| UBS | Ashwani Verma | Buy | 1 Sep 2026 | 52.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Buy | 20 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:04 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.